zydus-life-launches-anvimo-for-hsct News in Hindi -1 News Headlines Found

Zydus Life launches ANVIMO for HSCT, Kidney transplant treatment
Mumbai, Mar 5 (UNI) Pharma major, Zydus Lifesciences on Wednesday said that it has launched ANVIMO (Letermovir), a new and innovative treatment for the prevention of Cytomegalovirus (CMV) infection in Hematopoietic Stem Cell Transplantation (HSCT) and kidney transplant patients.
#Zydus Life launches ANVIMO for HSCT #Kidney transplant treatment